|
⚲
|
| Keyboard |
| Roberts EIRY
✚
|
|
|---|---|
| CIK # | 0001727606 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727606] | |
| 4 | [0001727606] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bausch Health Companies Inc | |
| Roberts EIRY | |
| Amicus Therapeutics Inc | |
| Neurocrine Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amicus Therapeutics Inc FOLD
Stock Options (right to buy) · derivative
|
2025-06-05 | Grant | 74,872 | $0.00 | |
|
Amicus Therapeutics Inc FOLD
Common Stock
|
2025-06-05 | Grant | 20,414 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-14 | Sell | 500 | $115.04 | 57,520 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Option exercise | 1,120 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Option exercise | 2,113 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Sell | 1,114 | $116.90 | 130,227 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-02-13 | Option exercise | 2,113 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Sell | 604 | $116.74 | 70,511 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Option exercise | 1,372 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-02-13 | Option exercise | 1,372 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-02-13 | Option exercise | 1,120 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2025-02-12 | Grant | 43,261 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-02-12 | Grant | 8,108 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-10 | Sell | 980 | $118.22 | 115,856 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-02-08 | Option exercise | 1,860 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-08 | Option exercise | 1,860 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-01-31 | Option exercise | 2,769 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-01-31 | Option exercise | 2,769 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-01-31 | Sell | 1,457 | $152.80 | 222,630 |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2024-12-17 | Grant | 27,770 | $0.00 | |
| showing 20 of 108 most recent transactions | |||||